ILFACILLIN P.S (200+250)MG/ML, ενέσιμο εναιώρημα
ILFACILLIN P.S (200+250)MG/ML, ενέσιμο εναιώρημα
Authorised
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine monohydrate
Product identification
Medicine name:
ILFACILLIN P.S (200+250)MG/ML, ενέσιμο εναιώρημα
Active substance:
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine monohydrate
Target species:
-
Cattle
-
Sheep
-
Pig
-
Dog
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Dihydrostreptomycin sulfate250.00/milligram(s)1.00millilitre(s)
-
Benzylpenicillin procaine monohydrate200.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal23day
-
Milk48hour
-
-
Sheep
-
Meat and offal31dayνα μη χορηγείται σε πρόβατα που παράγουν γάλα για ανθρώπινη κατανάλωση
-
-
Pig
-
Meat and offal20day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Hellafarm S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Ltd
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 18566/14-02-2024/K-0070901
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 26/08/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 26/08/2024